{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:55:13Z","timestamp":1781081713060,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ebiom.2022.104314","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T20:40:43Z","timestamp":1667076043000},"page":"104314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Long-term progression of retinal degeneration in a preclinical model of CLN7 Batten disease as a baseline for testing clinical therapeutics"],"prefix":"10.1016","volume":"85","author":[{"given":"Ashley A.","family":"Rowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0645-6319","authenticated-orcid":false,"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Nettesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacine","family":"Issioui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souad","family":"Messahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima N.","family":"Kayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Wert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S2","key":"10.1016\/j.ebiom.2022.104314_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1684\/epd.2016.0844","article-title":"Neuronal ceroid lipofuscinoses","volume":"18","author":"Nita","year":"2016","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.ebiom.2022.104314_bib2","author":"Chang"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104314_bib3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0883073813494268","article-title":"Classification and natural history of the neuronal ceroid lipofuscinoses","volume":"28","author":"Mink","year":"2013","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.ebiom.2022.104314_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2660(01)45002-4","article-title":"Neuronal ceroid lipofuscinoses: classification and diagnosis","volume":"45","author":"Wisniewski","year":"2001","journal-title":"Adv Genet"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104314_bib5","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1212\/WNL.57.4.576","article-title":"Pheno\/genotypic correlations of neuronal ceroid lipofuscinoses","volume":"57","author":"Wisniewski","year":"2001","journal-title":"Neurology"},{"issue":"10 Pt B","key":"10.1016\/j.ebiom.2022.104314_bib6","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.bbadis.2015.04.027","article-title":"Cell biology of the NCL proteins: what they do and don't do","volume":"1852","author":"C\u00e1rcel-Trullols","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104314_bib7","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1167\/iovs.16-20608","article-title":"Specific alleles of CLN7\/MFSD8, a protein that localizes to photoreceptor synaptic terminals, cause a spectrum of nonsyndromic retinal dystrophy","volume":"58","author":"Khan","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ebiom.2022.104314_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.866983","article-title":"Experimental therapeutic approaches for the treatment of retinal pathology in neuronal ceroid lipofuscinoses","volume":"13","author":"Bartsch","year":"2022","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104314_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40263-019-00620-8","article-title":"Current and emerging treatment strategies for neuronal ceroid lipofuscinoses","volume":"33","author":"Kohlschutter","year":"2019","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104314_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3171\/2021.7.PEDS21129","article-title":"A\u00a0survival analysis of ventricular access devices for delivery of cerliponase alfa","volume":"29","author":"Craven","year":"2022","journal-title":"J\u00a0Neurosurg Pediatr"},{"key":"10.1016\/j.ebiom.2022.104314_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejpn.2020.12.002","article-title":"Cerliponase alfa changes the natural history of children with neuronal ceroid lipofuscinosis type 2: the first French cohort","volume":"30","author":"Estublier","year":"2021","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104314_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","article-title":"Therapeutic landscape for Batten disease: current treatments and future prospects","volume":"15","author":"Johnson","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104314_bib13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/0883073819895694","article-title":"Review of cerliponase alfa: recombinant human enzyme replacement therapy for late-infantile neuronal ceroid lipofuscinosis type 2","volume":"35","author":"Lewis","year":"2020","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.ebiom.2022.104314_bib14","series-title":"Indication: For the Treatment of Neuronal Ceroid Lipofuscinosis Type 2 (Cln2) Disease, Also Known as Tripeptidyl Peptidase 1 (TPP1) Deficiency. CADTH Common Drug Review","article-title":"Pharmacoeconomic Review Report: cerliponase Alfa (Brineura)","year":"2019"},{"issue":"Pt 3","key":"10.1016\/j.ebiom.2022.104314_bib15","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/brain\/awn366","article-title":"Mutations in CLN7\/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis","volume":"132","author":"Kousi","year":"2009","journal-title":"Brain"},{"issue":"10 Pt B","key":"10.1016\/j.ebiom.2022.104314_bib16","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ebiom.2022.104314_bib17","author":"MedlinePlus"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104314_bib18","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1167\/iovs.16-20158","article-title":"Retinal degeneration in mice deficient in the lysosomal membrane protein CLN7","volume":"57","author":"Jankowiak","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104314_bib19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/hmg\/ddv615","article-title":"Lysosomal dysfunction and impaired autophagy in a novel mouse model deficient for the lysosomal membrane protein Cln7","volume":"25","author":"Brandenstein","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104314_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146286","article-title":"AAV9\/MFSD8 gene therapy is effective in preclinical models of neuronal ceroid lipofuscinosis type 7 disease","volume":"132","author":"Chen","year":"2022","journal-title":"J\u00a0Clin Invest"},{"issue":"17","key":"10.1016\/j.ebiom.2022.104314_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150898","article-title":"Replenishment of TCA cycle intermediates provides photoreceptor resilience against neurodegeneration during progression of retinitis pigmentosa","volume":"6","author":"Rowe","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2022.104314_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102636","article-title":"Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration","volume":"52","author":"Wert","year":"2020","journal-title":"EBioMedicine"},{"issue":"16","key":"10.1016\/j.ebiom.2022.104314_bib23","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1093\/hmg\/ddv189","article-title":"CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model","volume":"24","author":"Wert","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104314_bib24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/hmg\/dds466","article-title":"Gene\u00a0therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa","volume":"22","author":"Wert","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104314_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/hmg\/ddt452","article-title":"Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa","volume":"23","author":"Wert","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104314_bib26","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/hmg\/ddt661","article-title":"Functional validation of a human CAPN5 exome variant by lentiviral transduction into mouse retina","volume":"23","author":"Wert","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104314_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tins.2003.11.005","article-title":"VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate","volume":"27","author":"Fremeau","year":"2004","journal-title":"Trends Neurosci"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104314_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1523\/JNEUROSCI.23-02-00518.2003","article-title":"Vesicular neurotransmitter transporter expression in developing postnatal rodent retina: GABA and glycine precede glutamate","volume":"23","author":"Johnson","year":"2003","journal-title":"J\u00a0Neurosci"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104314_bib29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/cne.10838","article-title":"Expression of vesicular glutamate transporter 1 in the mouse retina reveals temporal ordering in development of rod vs. cone and ON vs. OFF circuits","volume":"465","author":"Sherry","year":"2003","journal-title":"J\u00a0Comp Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104314_bib30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1213\/ANE.0000000000001689","article-title":"Anesthetic management of patients with inborn errors of metabolism","volume":"125","author":"Kloesel","year":"2017","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104314_bib31","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1213\/ANE.0000000000001887","article-title":"Lysosomal storage diseases: past, present, and future","volume":"125","author":"Richtsfeld","year":"2017","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104314_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng0501-92","article-title":"Gene therapy restores vision in a canine model of childhood blindness","volume":"28","author":"Acland","year":"2001","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104314_bib33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0002-9394(03)00913-9","article-title":"Thirty-year follow-up of a patient with leber congenital amaurosis and novel RPE65 mutations","volume":"137","author":"Al-Khayer","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104314_bib34","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/hmg\/ddp163","article-title":"Loss of cone photoreceptors caused by chromophore depletion is partially prevented by the artificial chromophore pro-drug, 9-cis-retinyl acetate","volume":"18","author":"Maeda","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104314_bib35","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1073\/pnas.95.6.3088","article-title":"Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis","volume":"95","author":"Morimura","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104314_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng712","article-title":"New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis","volume":"29","author":"Seeliger","year":"2001","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104314_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038310","article-title":"Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system","volume":"7","author":"Staropoli","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104314_bib38","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1167\/iovs.13-12945","article-title":"Apoptotic photoreceptor loss and altered expression of lysosomal proteins in the nclf mouse model of neuronal ceroid lipofuscinosis","volume":"54","author":"Bartsch","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104314_bib39","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.bbadis.2013.01.009","article-title":"Use of model organisms for the study of neuronal ceroid lipofuscinosis","volume":"1832","author":"Bond","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104314_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainresbull.2012.03.003","article-title":"Mouse models of neuronal ceroid lipofuscinoses: useful pre-clinical tools to delineate disease pathophysiology and validate therapeutics","volume":"88","author":"Shacka","year":"2012","journal-title":"Brain Res Bull"},{"issue":"24","key":"10.1016\/j.ebiom.2022.104314_bib41","first-page":"7060","article-title":"Photoreceptor phagosome processing defects and disturbed autophagy in retinal pigment epithelium of Cln3Deltaex1-6 mice modelling juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"24","author":"Wavre-Shapton","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"13\u201314","key":"10.1016\/j.ebiom.2022.104314_bib42","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/hum.2020.038","article-title":"Gene therapy targeting the inner retina rescues the retinal phenotype in a mouse model of CLN3 Batten disease","volume":"31","author":"Kleine Holthaus","year":"2020","journal-title":"Hum Gene Ther"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104314_bib43","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ymthe.2018.02.027","article-title":"Prevention of photoreceptor cell loss in a Cln6(nclf) mouse model of Batten disease requires CLN6 gene transfer to bipolar cells","volume":"26","author":"Kleine Holthaus","year":"2018","journal-title":"Mol Ther"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104314_bib44","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1460-9592.2004.01401.x","article-title":"Anesthesia in a child with Batten disease","volume":"14","author":"Gopalakrishnan","year":"2004","journal-title":"Paediatr Anaesth"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104314_bib45","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41467-022-28191-1","article-title":"Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis","volume":"13","author":"Lopez-Fabuel","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104314_bib46","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013742","article-title":"Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype","volume":"13","author":"Soldati","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ebiom.2022.104314_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.exer.2015.08.018","article-title":"Lysosomes: regulators of autophagy in the retinal pigmented epithelium","volume":"144","author":"Sinha","year":"2016","journal-title":"Exp Eye Res"},{"issue":"51","key":"10.1016\/j.ebiom.2022.104314_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj9608","article-title":"CLN7 is an organellar chloride channel regulating lysosomal function","volume":"7","author":"Wang","year":"2021","journal-title":"Sci Adv"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:20:24Z","timestamp":1762456824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422004960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":48,"alternative-id":["S2352396422004960"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104314","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term progression of retinal degeneration in a preclinical model of CLN7 Batten disease as a baseline for testing clinical therapeutics","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104314"}}